Trials / Unknown
UnknownNCT03018236
Effect of N-acetylcysteine on Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.
The Effect of N-acetylcysteine (NAC) on Treatment of Alcohol and Cocaine Use Disorders: A Double-Blind Randomized Controlled Trial.
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- Hospital de Clinicas de Porto Alegre · Academic / Other
- Sex
- Male
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the use of N-acetylcysteine in the treatment of alcohol and cocaine use disorders. Alcohol users will be split in two groups, one will receive the active N-acetylcysteine and the other placebo. The same division will occur with cocaine users. The effects of N-acetylcysteine in adherence, abstinence, psychiatric symptoms and stress biomarkers will be evaluated.
Detailed description
N-acetylcysteine acts replenishing the human body glutathione storages. Glutathione is an important antioxidant agent, and also modulates the N-methyl-D-aspartate (NMDA) glutamatergic receptor. Glutamate has been associated with the neuroadaptation related to substance use disorders, and thus it is considered a potential target for pharmacological interventions regarding these disorders. N-acetylcysteine also interacts with the cystine-glutamate antiporter on astrocytes hence increasing glutamate release into the extracellular space. N-acetylcysteine effects and its implications in the addiction disorders have been studied initially with animal models. Glutamate levels normalization through N-acetylcysteine reduced compulsive drug self-administration and drug-seeking behavior in mice. In addition, there are promising results also with human subjects, showing benefits for cocaine, alcohol and cannabis use disorders. This study consists of a randomized, double-blind, placebo controlled trial with four arms: alcohol users divided into NAC vs Placebo and cocaine users divided into NAC vs Placebo.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Alcohol N-acetylcysteine | 1200 mg of NAC per day, taken in two doses, for subjects with alcohol use disorder |
| DRUG | Alcohol Placebo | Flour pills looking exactly the same as the active compound, for subjects with alcohol use disorder |
| DRUG | Cocaine N-acetylcysteine | 1200 mg of NAC per day, taken in two doses, for subjects with cocaine use disorder |
| DRUG | Cocaine Placebo | Flour pills looking exactly the same as the active compound, for subjects with cocaine use disorder |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-07-01
- Completion
- 2018-12-01
- First posted
- 2017-01-11
- Last updated
- 2017-01-24
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03018236. Inclusion in this directory is not an endorsement.